Dr. Shahla'a Fadhil Sabir

@uomustansiriyah.edu.iq

Laboratory Department
The National Center of Hematology

EDUCATION

PhD Clinical Immunology

RESEARCH INTERESTS

Clinical Immunology, Hematology and Genetics
38

Scholar Citations

4

Scholar h-index

RECENT SCHOLAR PUBLICATIONS

  • Evaluation of the relevance of serum level of interleukin-8 in chronic lymphocytic leukemia
    SF Sabir, HI Abd Al-Lateef, WA Hasan, DW Abed, AS Naji
    Iraqi Journal of Hematology 15 (1), 72-77 , 2026
    2026
  • Anti-CD33 Antibody-Drug Conjugate (Gemtuzumab ozogamicin) in Adult Acute Myeloid Leukemia: Real Life Data from Iraq
    AS Naji, LE Hammodi, SF Sabir, AS Hashim, AF Alwan
    Indian Journal of Hematology and Blood Transfusion, 1-5 , 2025
    2025
  • Correlation of serum interleukin-8 with disease severity in aplastic anemia
    SF Sabir, HI Abd AL-Lateef, NA Hamza
    Hematology, Transfusion and Cell Therapy 47 (4), 103989 , 2025
    2025
  • Knowledge, perception, and attitudes regarding the new COVID-19 delta variant pandemic among medical health workers and patients at the National Center of Hematology
    HI Abd AL-Lateef, SF Sabir, MM Ridha
    Reviews and Research in Medical Microbiology 36 (2), 57-61 , 2025
    2025
  • Immune reconstitution with high-dose chemotherapy and autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Prognostic factors and outcome from a …
    FS Yousif, BF Matti, SF Sabir, ZA Al-Bakri, SA Faraj, MA Mohammed, ...
    Transplant Immunology 89, 102182 , 2025
    2025
  • Serological and molecular detection of parvovirus B19 in hereditary bleeding disorder patients
    HI Abd Al-Lateef, SF Sabir, MM Khazeem, NKM Al-Rahal, ML Jabur
    Iraqi Journal of Hematology 14 (1), 117-122 , 2025
    2025
  • Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy
    SF Sabir, BF Matti, WMA Alwatar
    Immunogenetics 75 (2), 145-153 , 2023
    2023
    Citations: 4
  • Impact of programmed death 1 expression in chronic myeloid leukemia at different molecular responses to imatinib mesylate treatment
    SF Sabir, WMA Alwatar, BF Matti
    Biochem. Cell. Arch. 21 (1), 671-678 , 2021
    2021
    Citations: 1
  • Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response
    SF Sabir, WMA Alwatar, BF Matti
    Medico-legal Update 21 (1), 949-955 , 2021
    2021
    Citations: 2
  • Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors
    BF Matti, SF Sabir, MA Abdul Khaleq, MH Al Kaabi
    Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS) 17 (1), 213-221 , 2018
    2018
    Citations: 3
  • INTERLEUKIN 1β LEVEL AND C- REACTIVE PROTEIN ROLES IN PRIMARY MYELOFIBROSIS PATIENTS TREATED WITH HYDROXYUREA AND RUXOLITINIB
    Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah ...
    Int. Res. J. Pharm. 8 (6), 30-34 , 2017
    2017
  • Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis
    SF Sabir
    Iraqi Journal of Hematology 5 (2), 178 , 2016
    2016
  • The Correlation of Lipocalin-2 and Retinol Binding Protein-4 with the Inflammatory State in Iraqi Patients with T2DM
    SA Wadood, RS Al-Shawk, SF Sabir
    Iraqi Journal of Science 57 (2A), 802-807 , 2016
    2016
    Citations: 3
  • Discrimination of types of hypochromic microcytic anemia using screening laboratory test
    Abdulsalam Hatim Mohammed, Alea Frahan Salman, Shahla̛a Fadhil Sabir
    International Journal of Innovative and Applied Research 3 (2), 8-11 , 2015
    2015
  • Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy
    BF Matti, MA Saleem, SF Sabir
    Indian Journal of Hematology and Blood Transfusion 30 (4), 247-252 , 2014
    2014
    Citations: 9
  • Efficacy and Tolerance of Fludarabine and Cyclophosphamide (FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia
    B Matti, A Naji, A Alwan, A Majeed, S Saber
    Jordan Medical Journal 47 (4) , 2013
    2013
  • Incidence of JAK2 V617F Mutation in Iraqi Patients with Philadelphia Positive CML
    Marwah Hasan Ali Al-Kaabi, Yusra Ghiath Yaseen Al-Obaidy, Shahla'a Fadhil ...
    Mintage Journal of Pharmaceutical & Medical Sciences 2 (4), 10-12 , 2013
    2013
    Citations: 5
  • Assessment of GM-CSF Level in the Serum of Patients with Different Stages of Chronic Myeloid Leukemia Befor and After Imatinb Mesylate Therapy
    SF Sabir, MA Saleem, BF Matti
    Iraqi J. Hematology 2 (1), 7-13 , 2013
    2013
    Citations: 3
  • Combination therapy of Fludarabine and Cyclophosphamide(FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia
    BF Matti, AS Naji, AF Majid, SF Sabir, AF Alwan
    JFacMedBagdad 55 (1), 28-32 , 2013
    2013
  • Molecular screening for T315I and F317L resistance mutations in Iraqi chronic myeloid leukemia non-responders patients to imatinib
    MAR Dhahi, BF Matti, S Fadel
    Cancer Clin Oncol 2 (2), 55-61 , 2013
    2013
    Citations: 8

MOST CITED SCHOLAR PUBLICATIONS

  • Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy
    BF Matti, MA Saleem, SF Sabir
    Indian Journal of Hematology and Blood Transfusion 30 (4), 247-252 , 2014
    2014
    Citations: 9
  • Molecular screening for T315I and F317L resistance mutations in Iraqi chronic myeloid leukemia non-responders patients to imatinib
    MAR Dhahi, BF Matti, S Fadel
    Cancer Clin Oncol 2 (2), 55-61 , 2013
    2013
    Citations: 8
  • Incidence of JAK2 V617F Mutation in Iraqi Patients with Philadelphia Positive CML
    Marwah Hasan Ali Al-Kaabi, Yusra Ghiath Yaseen Al-Obaidy, Shahla'a Fadhil ...
    Mintage Journal of Pharmaceutical & Medical Sciences 2 (4), 10-12 , 2013
    2013
    Citations: 5
  • Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy
    SF Sabir, BF Matti, WMA Alwatar
    Immunogenetics 75 (2), 145-153 , 2023
    2023
    Citations: 4
  • Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors
    BF Matti, SF Sabir, MA Abdul Khaleq, MH Al Kaabi
    Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS) 17 (1), 213-221 , 2018
    2018
    Citations: 3
  • The Correlation of Lipocalin-2 and Retinol Binding Protein-4 with the Inflammatory State in Iraqi Patients with T2DM
    SA Wadood, RS Al-Shawk, SF Sabir
    Iraqi Journal of Science 57 (2A), 802-807 , 2016
    2016
    Citations: 3
  • Assessment of GM-CSF Level in the Serum of Patients with Different Stages of Chronic Myeloid Leukemia Befor and After Imatinb Mesylate Therapy
    SF Sabir, MA Saleem, BF Matti
    Iraqi J. Hematology 2 (1), 7-13 , 2013
    2013
    Citations: 3
  • Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response
    SF Sabir, WMA Alwatar, BF Matti
    Medico-legal Update 21 (1), 949-955 , 2021
    2021
    Citations: 2
  • Impact of programmed death 1 expression in chronic myeloid leukemia at different molecular responses to imatinib mesylate treatment
    SF Sabir, WMA Alwatar, BF Matti
    Biochem. Cell. Arch. 21 (1), 671-678 , 2021
    2021
    Citations: 1
  • Evaluation of the relevance of serum level of interleukin-8 in chronic lymphocytic leukemia
    SF Sabir, HI Abd Al-Lateef, WA Hasan, DW Abed, AS Naji
    Iraqi Journal of Hematology 15 (1), 72-77 , 2026
    2026
  • Anti-CD33 Antibody-Drug Conjugate (Gemtuzumab ozogamicin) in Adult Acute Myeloid Leukemia: Real Life Data from Iraq
    AS Naji, LE Hammodi, SF Sabir, AS Hashim, AF Alwan
    Indian Journal of Hematology and Blood Transfusion, 1-5 , 2025
    2025
  • Correlation of serum interleukin-8 with disease severity in aplastic anemia
    SF Sabir, HI Abd AL-Lateef, NA Hamza
    Hematology, Transfusion and Cell Therapy 47 (4), 103989 , 2025
    2025
  • Knowledge, perception, and attitudes regarding the new COVID-19 delta variant pandemic among medical health workers and patients at the National Center of Hematology
    HI Abd AL-Lateef, SF Sabir, MM Ridha
    Reviews and Research in Medical Microbiology 36 (2), 57-61 , 2025
    2025
  • Immune reconstitution with high-dose chemotherapy and autologous stem cell transplantation in refractory and relapsed Hodgkin lymphoma: Prognostic factors and outcome from a …
    FS Yousif, BF Matti, SF Sabir, ZA Al-Bakri, SA Faraj, MA Mohammed, ...
    Transplant Immunology 89, 102182 , 2025
    2025
  • Serological and molecular detection of parvovirus B19 in hereditary bleeding disorder patients
    HI Abd Al-Lateef, SF Sabir, MM Khazeem, NKM Al-Rahal, ML Jabur
    Iraqi Journal of Hematology 14 (1), 117-122 , 2025
    2025
  • INTERLEUKIN 1β LEVEL AND C- REACTIVE PROTEIN ROLES IN PRIMARY MYELOFIBROSIS PATIENTS TREATED WITH HYDROXYUREA AND RUXOLITINIB
    Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah ...
    Int. Res. J. Pharm. 8 (6), 30-34 , 2017
    2017
  • Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis
    SF Sabir
    Iraqi Journal of Hematology 5 (2), 178 , 2016
    2016
  • Discrimination of types of hypochromic microcytic anemia using screening laboratory test
    Abdulsalam Hatim Mohammed, Alea Frahan Salman, Shahla̛a Fadhil Sabir
    International Journal of Innovative and Applied Research 3 (2), 8-11 , 2015
    2015
  • Efficacy and Tolerance of Fludarabine and Cyclophosphamide (FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia
    B Matti, A Naji, A Alwan, A Majeed, S Saber
    Jordan Medical Journal 47 (4) , 2013
    2013
  • Combination therapy of Fludarabine and Cyclophosphamide(FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia
    BF Matti, AS Naji, AF Majid, SF Sabir, AF Alwan
    JFacMedBagdad 55 (1), 28-32 , 2013
    2013